Table 3. Syphilis screening recommendations in pregnant women, by level of maternal syphilis seroprevalence in country (n = 115 countries*).
Maternal syphilis prevalence <1% (n = 73 countries) | Maternal syphilis prevalence ≥1% (n = 42 countries) | p-value | |
---|---|---|---|
Universal screening | |||
Recommended | 71 (97%) | 40 (95%) | 0.57 |
Time of the first screening | |||
At the first trimester | 50 (69%) | 12 (29%) | <0.01 |
At the first ANC visit | 17 (24%) | 23 (55%) | |
Not reported | 6 (7%) | 7 (16%) | |
Repeat screening during pregnancy | |||
Yes, universal | 20 (27%) | 20 (48%) | <0.01 |
Yes, only high risk | 45 (62%) | 7 (16%) | |
Not reported | 8 (11%) | 15 (36%) | |
Screening during delivery | |||
Yes, always | 11(15%) | 11 (26%) | <0.01 |
Yes, if no evidence of prior screening | 3 (4%) | 2 (5%) | |
Yes, if at risk | 45 (62%) | 10 (24%) | |
Not reported | 14 (19%) | 19 (45%) |
*13 countries had no available maternal syphilis seroprevalence data.